PA Consulting Group
Please enter search term
Search our site
Contact PA Consulting Group now for more information

United Kingdom
+44 (0)20 7333 5869

United States
+1 212 973 5943

or for further information visit www.paconsulting.com/contact
  • Phone
  • Contact us
  • Locations
  • Search
  • Menu

share

  • Add this article to your LinkedIn page
  • Add this article to your Twitter feed
  • Add this article to your Facebook page
.
Picture of people in a laboratory

"It is important for device companies to recognise the increased technical and commercial challenges that are faced when developing this type of product."

GREGORY BERMAN, EXPERT IN DRUG DELIVERY, PA CONSULTING GROUP

Combined efforts - realising the commercial potential of combination products

 An extract article from Impacts volume 7

Convergence therapies have been defined as ‘the combination in a single product of device and pharmaceutical and/or biological therapies’ and have been referred to as the medical device industry’s ‘most promising opportunity ever’.

This area holds the potential for delivering major benefits, not just in regard to better treatments, but also significant financial reward to successful developers of combination products.

However, before leaping into this space it is important for device companies to recognise the increased technical and commercial challenges that are faced when developing this type of product.

How can device companies learn from the experiences of early pioneers in this field, develop a strategy that is able to see past the core science and focus on delivering the full business package necessary for commercial success?

This article explores some of the opportunities and challenges (technological, regulatory and marketing) in developing device strategy through to implementation.

Read the full article on combination products

 

To find out more about how PA can help you gain value from combination products, please contact us now.

Contact
Richard McIntyre
Healthcare consulting
contact us now